WGS Q4 2023 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q4 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$57M-6.4% YoY

Gross Profit

$31M53.6% margin

Operating Income

-$26M-44.7% margin

Net Income

-$26M-44.9% margin

EPS (Diluted)

$-0.99

QoQ Revenue Growth

+7.7%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

-$912,000

Balance Sheet

Total Assets

$419M

Total Liabilities

$191M

Stockholders' Equity

$228M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$61M	-6.4%
Gross Profit	$31M	-$16M	+288.4%
Operating Income	-$26M	-$325M	+92.1%
Net Income	-$26M	-$309M	+91.7%